The regulatory role of AP-2β in monoaminergic neurotransmitter systems: insights on its signalling pathway, linked disorders and theragnostic potential
Open Access
- 8 September 2022
- journal article
- review article
- Published by Springer Nature in Cell & Bioscience
- Vol. 12 (1) , 1-20
Abstract
Monoaminergic neurotransmitter systems play a central role in neuronal function and behaviour. Dysregulation of these systems gives rise to neuropsychiatric and neurodegenerative disorders with high prevalence and societal burden, collectively termed monoamine neurotransmitter disorders (MNDs). Despite extensive research, the transcriptional regulation of monoaminergic neurotransmitter systems is not fully explored. Interestingly, certain drugs that act on these systems have been shown to modulate central levels of the transcription factor AP-2 beta (AP-2β, gene: TFAP2Β). AP-2β regulates multiple key genes within these systems and thereby its levels correlate with monoamine neurotransmitters measures; yet, its signalling pathways are not well understood. Moreover, although dysregulation of TFAP2Β has been associated with MNDs, the underlying mechanisms for these associations remain elusive. In this context, this review addresses AP-2β, considering its basic structural aspects, regulation and signalling pathways in the controlling of monoaminergic neurotransmitter systems, and possible mechanisms underpinning associated MNDS. It also underscores the significance of AP-2β as a potential diagnostic biomarker and its potential and limitations as a therapeutic target for specific MNDs as well as possible pharmaceutical interventions for targeting it. In essence, this review emphasizes the role of AP-2β as a key regulator of the monoaminergic neurotransmitter systems and its importance for understanding the pathogenesis and improving the management of MNDs.Keywords
Funding Information
- Vetenskapsrådet
- Novo Nordisk Fonden
- Uppsala University
This publication has 293 references indexed in Scilit:
- AP-2β regulates amyloid beta-protein stimulation of apolipoprotein E transcription in astrocytesBrain Research, 2012
- Transcription factor AP-2β regulates the neurotransmitter phenotype and maturation of chromaffin cellsMolecular and Cellular Neuroscience, 2011
- Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence2011
- Role of the Serotonergic System in Alcohol Dependence2011
- Disorganized olfactory bulb lamination in mice deficient for transcription factor AP-2ɛMolecular and Cellular Neuroscience, 2009
- Role of serotonin and dopamine system interactions in the neurobiology of impulsive aggression and its comorbidity with other clinical disordersAggression and Violent Behavior, 2008
- Regulation of the Noradrenaline Neurotransmitter Phenotype by the Transcription Factor AP-2βJournal of Biological Chemistry, 2008
- MAOA methylation is associated with nicotine and alcohol dependence in womenAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2008
- Serotonin Transporter Promoter Gain-of-Function Genotypes Are Linked to Obsessive-Compulsive DisorderThe American Journal of Human Genetics, 2006
- GAS41 interacts with transcription factor AP-2 and stimulates AP-2 -mediated transactivationNucleic Acids Research, 2006